Kidney Transplant Outcomes Stratified by Age with a Calcineurin and Steroid Free Regimen

被引:0
|
作者
Scalzo, R. [1 ]
Harris, M. [1 ]
Morris, J. [2 ]
Byrns, J. [1 ]
机构
[1] Duke Univ Hosp, Pharm, Durham, NC USA
[2] Duke Univ Hosp, Nephrol, Durham, NC USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
943
引用
收藏
页码:696 / 696
页数:1
相关论文
共 50 条
  • [1] Kidney Transplant Outcomes Stratified by Race with a Calcineurin and Steroid Free Regimen
    Scalzo, R. E.
    Harris, M. T.
    Morris, J. D.
    Byrns, J. S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 695 - 696
  • [2] Alemtuzumab Preconditioning Allows Steroid-calcineurin Inhibitor-free Regimen in Live-donor Kidney Transplant
    Refaie, Ayman F.
    Mahmoud, Khaled M.
    Ismail, Amani M.
    Sheashaa, Hussein A.
    Kamal, Ahmed I.
    Ghoneim, Mohamed A.
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2011, 9 (05) : 295 - 301
  • [3] Pre Transplant Donor Specific Antibodies and Clinical Outcomes in Kidney Transplant Recipient on Steroid Free Maintenance Immunosupression Regimen
    Adebiyi, O.
    Sharfuddin, A.
    Yaqub, M.
    Hussain, S.
    Mishler, D.
    Sharfuddin, A.
    Goggins, W.
    Taber, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 737 - 737
  • [4] Five Years Outcomes of Steroid Free African American Kidney Transplant Recipients: A Comparison of Calcineurin-Based and Calcineurin-Free Protocols.
    Marin, M.
    Goel, S. K.
    Yuan, H.
    El-Ghoroury, M. A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 443 - 444
  • [5] Long Term Outcomes of a Steroid Free, Low Dose Tacrolimus with Everolimus Regimen in Kidney Transplant.
    Kassis, Y.
    Park, S.
    Shetty, A.
    Leventhal, J.
    Mas, V.
    Gallon, L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 800 - 801
  • [6] Conversion from sirolimus to everolimus in kidney transplant recipients receiving a calcineurin-free regimen
    Carvalho, Catarina
    Coentrao, Luis
    Bustorff, Manuela
    Patricio, Emilia
    Sampaio, Susana
    Santos, Joana
    Oliveira, Gerardo
    Pestana, Manuel
    CLINICAL TRANSPLANTATION, 2011, 25 (04) : E401 - E405
  • [7] BK nephropathy in kidney transplant recipients treated with a calcineurin inhibitor-free immunosuppression regimen
    Lipshutz, GS
    Flechner, SM
    Govani, MV
    Vincenti, F
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (12) : 2132 - 2134
  • [8] GFR-estimating models in kidney transplant recipients on a steroid-free regimen
    Kukla, Aleksandra
    El-Shahawi, Yasser
    Leister, Erin
    Kasiske, Bertram
    Mauer, Michael
    Matas, Arthur
    Ibrahim, Hassan N.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (05) : 1653 - 1661
  • [9] Long-Term Infectious and Noninfectious Outcomes of Monthly Alemtuzumab as a Calcineurin Inhibitor- and Steroid-Free Regimen for Pancreas Transplant Recipients
    Kaplan, Adam
    Young, Jo-Anne H.
    Kandaswamy, Raja
    Berglund, Danielle
    Knoll, Bettina M.
    Sieger, Gretchen
    Cavert, Winston
    Matas, Arthur
    Obeid, Karam M.
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2020, 2020
  • [10] Early calcineurin-inhibitor to belatacept conversion in steroid-free kidney transplant recipients
    Tawhari, Ibrahim
    Hallak, Patrick
    Bin, Sofia
    Yamani, Fatmah
    Safar-Boueri, Maria
    Irshad, Aazib
    Leventhal, Joseph
    Ansari, Mohammed Javeed
    Cravedi, Paolo
    Gallon, Lorenzo
    FRONTIERS IN IMMUNOLOGY, 2022, 13